Lorianne Masuoka K. 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
Lorianne Masuoka K.
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2024-01-22+285,000→ 285,000 totalExercise: $2.79Exp: 2034-01-21→ Common Shares (285,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on January 22, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on April 1, 2025.